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nISUALIZING INSIDE THE CELL
hosphoprotein Analysis at the Single Cell Level
When one considers the manner in which the
mmune system operates, the picture that comes to
ind are often of cells interacting individually and
hysically with other cells. At a global level the inter-
lay of many such cell-cell interactions, the commu-
ication that pass between such cells, and the deci-
ions these cells ﬁnally make eventually constitute a
ommitment to a dedicated immune outcome. When
ne next considers the signaling processes that occur
ithin an individual cell, the mind conjures a wiring
iagram in which signals passed from the cell surface
ow like blinking lights up and down pathways of
nformation conduits, often reaching into the nucleus
o activate gene programs, cause the release of cyto-
ines, or otherwise change basic cellular processes to
nact a ﬁnal immune system function.
For the past 30 yr simply knowing the relative
umber of B cells, T cells, macrophages, monocytes,
nd all of the other varied immune cell constituents
rovides us with signiﬁcant understanding about how
he immune system operates. The conventional ap-
roach by which one understands the relative number
f various immune cell subsets has been through the
se of ﬂow cytometry. Abs speciﬁc to surface protein
pitopes that demarcate immune cell subsets are con-
ugated with ﬂuorophores and then used to tag such
ells for cytometric analysis. As such, ﬂow cytometric
pplications in recent years have become extremely
ophisticated, and it is now commonplace for labora-
ories to apply 4-10 different Abs simultaneously to
ollow immune cell subsets in multiparameter ﬂow.
he advantages of ﬂow cytometry are not only the
imple counting of what cells have what protein mark-
rs expressed at their cell surface, but the amazingly
ccurate quantitation of the amount of such proteins
sing ﬂow cytometric machines that are appropriately
uned. The beneﬁts ﬂow cytometry has provided to
ur understanding of everything from differentiation
f the immune system, graft rejection, tolerance, vac-
ine utility, to autoimmunity are far too numerous to c
20etail here. However, analysis of immune cell function
as until recently stopped short of understanding the
iochemical events that occur within individual cells.
he techniques and approaches in addition to the
isualizations of network operations at the single cell
evel have not been well developed.
An accepted indicator of signaling function status
s phosphorylation downstream of kinase activation
vents. Phosphorylation at speciﬁc residues on pro-
eins not only is a relatively stable and useful reﬂection
f the recent events and history of a cell but also can
e a useful predictor of what the cell is capable of
ccomplishing in the future depending on the envi-
onment in which it ﬁnds itself. Given this, the Nolan
aboratory has spent considerable effort developing
nd validating Abs that are capable of binding to
peciﬁc phosphorylated epitopes found on important
egulatory proteins in signaling processes [1-9]. Our
rst entry into this area was the demonstration that we
ould simultaneously stain for up to 11 different in-
racellular kinases or their phosphorylated targets
rom primary human cells such as those derived from
hole human blood [9]. This study set the stage for
ater mechanistic analyses of signaling function driven
y integrins in T cells [9] and NK cells [7] and dem-
nstrated that subset speciﬁc signaling could be ana-
yzed at the single-cell level by ﬂow cytometric ap-
roaches. Later studies showed that it was possible to
imultaneously analyze multiple cell subsets and mul-
iple kinase signaling events in individual patients or
nimals, essentially allowing one to create a phospho-
roteomic map of immune signaling function using
rimary single cells [3,4].
otentiated Signaling and Interrogations Reveal
etwork Structures in Cells
A critical advance to our understanding of how to
nterpret kinase signaling at the single-cell level was
he realization that using the basal phosphorylation
evels of proteins from resting cells out of the blood
id not provide sufﬁcient information to correlate
etwork status with disease outcome. Using leukemia
ells from patients with AML we showed that by
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Visualizing Inside the Cell 121nterrogating cells independently with multiple differ-
nt cytokines, and measuring the effects that such
nvironmental cues had on cellular signaling provided
ich datasets that could be used to stratify patients that
ould respond to chemotherapy apart from those pa-
ients who would not respond to chemotherapy [2,10].
uch an approach allows for providing patients with a
rognostication outcome before their undergoing
hemotherapy and could suggest that some patients
hould not undergo a speciﬁc chemotherapy treat-
ent (because it would provide no beneﬁt for them).
urther, this study demonstrated that as disease
rogresses signaling becomes more dysregulated, and
he cancer actually develops into multiple subclones,
ach of which has distinct signaling phenotypes
Figure 1). Because the 3 patients on the left side (P27,
26, and P23) of the panel had an initial regression of
he tumor after chemotherapy treatment (with dauno-
ubicin and a topoisomerase inhibitor), one presumes
he bulk tumor seen in those patients disappears.
Given that the patients on the right side of the
anel did not show regression of tumor, at the very
east one would expect that the upper right-hand pop-
lation of cells is resistant to the chemotherapy. In-
erestingly, both chemoresistant patients show a re-
idual population of cells that is similar in signaling to
he primary population seen in patients who re-
igure 1. A potential clinical progression map. The x and y axes of e
anels show the relative level of each of these phosphoproteins in
ed circle in the ﬁrst of the 3 panels demonstrating where no
hosphorylation. Two groups of patients are shown: those with g
egative prognostic outcomes (patients P14 and P11). The topmost
hen staining for p-Stat3 and p-Stat5. In the upper panel, note the a
in patients P14 and P11 especially). In addition, patients P26 and
uggestive in these ﬁgures that the subpopulations demarcated by th
opulations such as seen in P14 and P11. This ﬁgure is identical to
o be presented by Dr Nolan in autumn 2006.ponded to chemotherapy. In addition, 2 of the pa-
ients who initially responded to the chemotherapy
howed a small population of cells that looked like the
ulk population in the resistant patients. Although yet
o be proved, this would suggest a hypothesis in which
atients start with a dysplastic AML-like disease that is
lightly dysregulated in its signaling potential, is
argely nonresponsive to outside cues, but is respon-
ive to chemotherapy induction of apoptotic signaling.
owever, as the cancer progresses, it evolves into
ifferent signaling clonotypes, each of which has a
istinct signature and some of which apparently are
ssentially resistant to the apoptosis inducing effects
f the applied chemotherapy. Thus, it should be
ossible to segregate patients’ subclones according
o how they respond to individual therapies and
ualify the effects directly with a diagnostic for the
fﬁcacy. Using this basic approach we have been
ndertaking a large-scale clinical trial with patients
ith follicular lymphoma (J. Irish, Garry Philip
olan, and R. Levy) and initial studies on children
ith Juvenile Myelomonocytic Leukemia (N. Ko-
echa, GPN, and M. Lo). In each of these latter
ases we have observed clear signaling event differ-
nces that distinguish the cancer cell from normal
ell precursors or allows for the visualization of the
ph show relative quantitation of p-Stat-3 and p-Stat-5. The bottom
ells in unstimulated cells right out of the blood of patients, with a
ealthy Peripheral Blood Lymphocytes (PBL) would show basal
ognostic phenotype (patients P27, P26, and P23) and those with
show the same patient samples after stimulation with G-CSF and
nce of multiple signaling clonotypes after stimulation with G-GSF
ow initial indications of the formation of these populations. It is
vals will eventually evolve into aggressively chemotherapy-resistant
used in an American Society of Hematology Educational Lectureach gra
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G. Nolan122ancer cells clearly from normal cell counterparts in
he blood [11,12].
achine Learning to Derive Signaling Pathway
tructures from Raw Flow Data
One objective of such studies is to not only reveal
signatures” or biomarkers that might relate to disease
rogress or drug action but also to understand the
undamental attributes of the signaling networks in
rimary cell populations. However, conventional ap-
roaches to biochemical analysis in primary cells are
imply not feasible. In many cases primary cell mate-
ial from patients is limited. Standard analysis would
nclude overexpression of the signaling protein up-
tream of downstream signaling events, and if the
ownstream events were driven to higher levels of
ctivity or lower, a connection would be derived con-
isting of an arrow indicating upregulation or a block-
de event. Even if we were to apply phosphoﬂow
pproaches using multiple simultaneous stains, say 11,
or phosphorylated epitopes within cells to look for
orrelated changes between phosphoepitopes, one
ould quickly reach the limit of human focus when
ttempting to search for correlations in an 11-dimen-
ional space! For this reason we decided to determine
f one could use applications of machine learning and
rtiﬁcial intelligence to discern signaling correlations
ith such multidimensional datasets. In a report pub-
ished last year we showed it was possible to use
rimary CD4 T cells from humans, stimulate them
ith multiple environmental cues (perturbations) to
nitiate cell signaling, apply inhibitory agents that
ere presumed to act on kinases within the signaling
athways being studied, and use an advanced applica-
ion of Bayesian network analysis to derive the under-
ying signaling network [13]. As shown in that Science
eport we were able to readily derive from the raw data
f an 11-dimensional multiparameter stain of phos-
hoepitopes the correct signaling map, at least as
nown to the literature. The suggested the correlative
atasets analyzed measure across the multiparametrics
pace could, provides an opportunity to automate the
erivation of signaling map structures directly from
rimary cells right out of patient material. This could
llow for one to represent ﬂow symmetric data not
imply as the presence or absence of certain proteins
ithin cells or on the surface of cells. It is exciting to
ealize that this could allow for the representation of
ellular material as derived from patients directly as
ignaling map differences as found in different cellular
ubsets.
One limitation to this study was that deriving the
ignaling map structure required for us to run the
atasets on the MIT supercomputer cluster. This was
ecessitated by the astronomically large number of
terative maps that had to be considered by the Bayes-
an algorithm and the computational requirements. A Solution to this problem was developed recently by
yron Ellis and Wing Wong (unpublished) using our
ploaded Science dataset. They used a different Bayes-
an approach and managed to get the analysis down to
pproximately 10 min on an Apple G4, representing a
onsiderable increase in speed. However, for the pur-
oses of where the analysis needs to go, we have taken
further step through the use of ﬁeld programmable
ate array (FPGA) technology. Essentially, FPGAs are
rogrammable logic units onto which one can directly
ncode logic circuits of any type in a read/write fash-
on (in principle FPGAs are similar to the memory
ircuits that we use currently in digital cameras). An
nterface software module has been developed in
ollaboration with B. Ellis (Stanford), W. Wong
Stanford), R. Broderson (Berkeley), N. B. Asadi,
nd T. Meng (Stanford) that can take higher-order
ATLAB equations (such as statistical equations,
ayesian algorithms, etc.) and translate them directly
nto logic circuits on the FPGA. Figure 2 (right-hand
anel) shows an example of the FPGA circuitry that
e are applying. Each of the FPGA boards contains
programmable CPUs and associated memory for
apid calculations and analysis. What this circuitry
ssentially accomplishes is a direct encoding of Bayes-
an logic speciﬁc for single-cell analysis and network
athway diagramming in primary cells. The estimated
peed enhancement of taking this approach is a nearly
0 000-fold decrease in the time required for calcula-
ion. This previously took overnight on an MIT su-
ercomputer cluster, then took as little as 10 min an
pple G4 laptop, and now can be achieved within
bout 1/10 of a second. What this will allow is for us
igure 2. Left-hand panel shows a signaling map derived from
D4 naive memory T cells from humans. Bayesian network anal-
sis was used to derive this pathway structure from the raw data of
1-dimensional phosphoepitope staining. Right-hand panel shows a
ogic board for an FPGA that is currently being used to encode
ayesian equations and other statistical programming speciﬁcally
or single-cell analysis of network structures from primary cellular
aterial. The left-hand panel is a reproduction of a ﬁgure in the
cience report discussed in text [13].
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Visualizing Inside the Cell 123o adapt standard ﬂow cytometric analysis to enable
ating of populations of cells that have been stained
or surface markers and intracellular phosphoepitopes
nd automate the rapid assembly of signaling net-
orks within the cell subpopulations. Appropriate al-
erations to the approach will also allow for one to
click” on a network diagram connection and ask the
omputer to represent the cells in the datasets that
ctually support the derivation of that network arc
onnection.
If there is a moral in the story, it would be that
here is reason to believe that the quantitative nature
f ﬂow cytometry can be applied with considerable
ffect to the biochemical analysis of cellular signaling
vents. At the single-cell level the laws of mass action
re truly at work. One can use this principle and the
uantitative nature of ﬂow to rapidly derive signaling
aps directly from patient material. In the near future
e expect to use the signaling maps and the underly-
ng connectivity attributes to cluster patients to out-
omes. Thus it is clear that ﬂow cytometry has arrived
t a point to allow far greater and accurate designation
f cellular signaling status in response to disease or
rug action.
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